TCRT Alaunos Therapeutics, Inc.
Fundamentals / CIK 0001107421 / USDAlaunos Therapeutics, Inc. reported $3.0K in revenue and a net loss of $3.62M for the trailing twelve months ended September 30, 2026 (down 50.0% year over year), with a -121033.3% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TCRT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$3.0K -50.0% YoY
-
Operating Income TTM-$3.63M -121033.3% margin
-
Net Income TTM-$3.62M -120766.7% net margin
-
Diluted EPS TTM-$1.39 Split-adjusted
-
Free Cash Flow TTM-$2.97M -98900.0% FCF margin
-
Cash & ST Investments Sep 30, 2026$615K Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.0K | $10K | $5.0K | $2.92M | $398K | $0 | -- | $146K | $15.90M | $6.86M |
| Research & Development | $1.36M | $362K | $16.28M | $25.02M | $49.64M | $52.70M | $38.33M | $34.13M | $45.08M | $157.8M |
| Total Operating Expenses | $4.23M | $4.82M | $34.27M | $38.03M | $77.95M | $80.36M | $57.86M | $54.05M | $59.88M | -- |
| Operating Income | -$4.22M | -$4.81M | -$34.27M | -$35.10M | -$77.55M | -$80.36M | -$57.86M | -$53.91M | -$53.49M | -$165.3M |
| EBITDA | -$4.22M | -$4.81M | -$31.95M | -$32.35M | -$74.95M | -$79.23M | -$57.23M | -$53.33M | -$53.12M | -$165.0M |
| Interest Expense | -- | $0 | $1.92M | $3.15M | $1.19M | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | -$4.18M | -$4.68M | -$4.68M | -$37.73M | -$78.75M | -$79.98M | -$117.8M | -$53.12M | -$54.32M | -$165.3M |
| Basic EPS | -$2.20 | -$2.92 | -$21.97 | -$3,895.52 | -$8,283.58 | -$8,507.46 | -$15,671.64 | $21,492.54 | -$11,865.67 | -$29,552.24 |
| Diluted EPS | -$2.20 | -$2.92 | -$21.97 | -$3,895.52 | -$8,283.58 | -$8,507.46 | -$15,671.64 | $21,492.54 | -$11,865.67 | -$29,552.24 |
| Basic Shares Outstanding | 1.9M | 1.6M | 1.6M | 9.7K | 9.6K | 9.4K | 7.5K | 6.4K | 6.1K | 5.8K |
| Diluted Shares Outstanding | 1.9M | 1.6M | 1.6M | 9.7K | 9.6K | 9.4K | 7.5K | 6.4K | 6.1K | 5.8K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $3.0K | $0 | $0 | $2.0K | $4.0K |
| Research & Development | $227K | $388K | $427K | $361K | $469K | $185K | $347K | -$86K |
| Total Operating Expenses | $760K | $952K | $1.01M | $910K | $1.19M | $1.04M | $1.09M | $759K |
| Operating Income | -$760K | -$952K | -$1.01M | -$907K | -$1.19M | -$1.04M | -$1.09M | -$755K |
| EBITDA | -$752K | -$943K | -$1.00M | -$900K | -$1.19M | -$1.04M | -$1.09M | -$756K |
| Net Income | -$772K | -$952K | -$1.01M | -$893K | -$1.16M | -$1.05M | -$1.07M | -$742K |
| Basic EPS | -$0.31 | -$0.41 | -$0.59 | -- | -$0.55 | -$0.63 | -$0.67 | -- |
| Diluted EPS | -$0.31 | -$0.41 | -$0.59 | -- | -$0.55 | -$0.63 | -$0.67 | -- |
| Basic Shares Outstanding | 2.6M | 2.4M | 1.9M | -- | 2.2M | 1.7M | 1.6M | -- |
| Diluted Shares Outstanding | 2.6M | 2.4M | 1.9M | -- | 2.2M | 1.7M | 1.6M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.39M | $1.09M | $6.06M | $39.06M | $76.05M | $115.1M | $79.74M | $61.73M | $70.95M | $81.05M |
| Cash & Short-Term Investments | $1.39M | $1.09M | $6.06M | $39.06M | $76.05M | $115.1M | $79.74M | $61.73M | $70.95M | $81.05M |
| Accounts Receivable, Net | $3.0K | $5.0K | $1.0K | $4.0K | $1.11M | $4.67M | $3.33M | $1.86M | $19K | $21K |
| Total Current Assets | $1.99M | $2.75M | $8.26M | $53.80M | $78.83M | $130.6M | $105.5M | $84.28M | $90.78M | $104.9M |
| Property, Plant & Equipment, Net | $91K | $0 | $2.0K | $8.46M | $10.94M | $10.23M | $1.11M | $1.10M | $1.21M | $843K |
| Other Non-Current Assets | -- | -- | $0 | $500K | $631K | $745K | $110K | $9.54M | $13.48M | $493K |
| Total Non-Current Assets | $978K | $0 | $2.0K | $11.14M | $16.03M | $15.76M | $3.62M | $10.77M | $14.82M | $1.46M |
| Total Assets | $2.97M | $2.75M | $8.26M | $64.94M | $94.86M | $146.3M | $109.1M | $95.05M | $105.6M | $106.3M |
| Accounts Payable | $613K | $516K | $616K | $1.39M | $1.37M | $960K | $906K | $707K | $4.42M | $156K |
| Short-Term Debt | -- | -- | $0 | $16.77M | $7.87M | $0 | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | -- | $6.39M | $6.39M |
| Total Current Liabilities | $813K | $692K | $1.96M | $24.17M | $16.04M | $18.37M | $12.53M | $9.48M | $20.86M | $15.81M |
| Long-Term Debt | -- | $0 | $0 | $0 | $16.25M | $0 | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | -- | $35.14M | $41.53M |
| Other Non-Current Liabilities | -- | -- | $0 | $28K | $0 | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $0 | $0 | $0 | $2.22M | $20.77M | $4.00M | $1.58M | $4.0K | $37.56M | $42.52M |
| Total Liabilities | $813K | $692K | $1.96M | $26.38M | $36.81M | $22.36M | $14.10M | $9.49M | $58.42M | $58.33M |
| Total Debt (incl. Leases) | -- | $0 | $0 | $22.26M | $34.61M | $9.63M | $4.70M | -- | -- | -- |
| Common Stock | $2.0K | $2.0K | $2.0K | $16K | $216K | $215K | $182K | $161K | $143K | $132K |
| Retained Earnings | -$924.6M | -$920.4M | -$915.8M | -$880.6M | -$842.9M | -$764.1M | -$684.1M | -$566.3M | -$712.4M | -$658.0M |
| Total Stockholders' Equity | $2.15M | $2.06M | $6.31M | $38.55M | $58.06M | $124.0M | $95.01M | $85.56M | -$96.81M | -$77.30M |
| Total Equity | $2.15M | $2.06M | $6.31M | $38.55M | $58.06M | $124.0M | $95.01M | $85.56M | -$96.81M | -$77.30M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $615K | $124K | $354K | $1.39M | $1.94M | $2.88M | $319K | $1.09M |
| Cash & Short-Term Investments | $615K | $124K | $354K | $1.39M | $1.94M | $2.88M | $319K | $1.09M |
| Accounts Receivable, Net | $0 | $0 | $0 | $3.0K | $0 | $2.0K | $2.0K | $5.0K |
| Total Current Assets | $1.08M | $666K | $970K | $1.99M | $2.69M | $3.74M | $1.07M | $2.75M |
| Property, Plant & Equipment, Net | $66K | $74K | $82K | $91K | $97K | -- | -- | $0 |
| Total Non-Current Assets | $842K | $850K | $913K | $978K | $1.04M | $997K | $1.05M | $0 |
| Total Assets | $1.92M | $1.52M | $1.88M | $2.97M | $3.72M | $4.74M | $2.12M | $2.75M |
| Accounts Payable | $796K | $732K | $400K | $613K | $843K | $809K | $831K | $516K |
| Total Current Liabilities | $947K | $864K | $595K | $813K | $921K | $1.07M | $1.06M | $692K |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $947K | $864K | $595K | $813K | $921K | $1.07M | $1.06M | $692K |
| Total Debt (incl. Leases) | -- | -- | -- | -- | -- | -- | -- | $0 |
| Common Stock | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$927.4M | -$926.6M | -$925.6M | -$924.6M | -$923.7M | -$922.6M | -$921.5M | -$920.4M |
| Total Stockholders' Equity | $971K | $652K | $1.29M | $2.15M | $2.80M | $3.66M | $1.06M | $2.06M |
| Total Equity | $971K | $652K | $1.29M | $2.15M | $2.80M | $3.66M | $1.06M | $2.06M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$4.18M | -$4.68M | -$4.68M | -$37.73M | -$78.75M | -$79.98M | -$117.8M | -$53.12M | -$54.32M | -$165.3M |
| Depreciation & Amortization | $7.0K | $2.0K | $2.31M | $2.76M | $2.60M | $1.13M | $629K | $575K | $369K | $290K |
| Stock-Based Compensation | $796K | $435K | $2.80M | $3.53M | $10.77M | $6.83M | $6.34M | $7.53M | $8.45M | $8.45M |
| Change in Receivables | $2.0K | -$4.0K | $3.0K | $1.11M | $3.56M | -$1.33M | -$1.47M | -$1.84M | $2.0K | $425K |
| Change in Payables | $97K | -$100K | -$773K | -$25K | $274K | $54K | $199K | -$3.71M | $4.26M | -$1.85M |
| Operating Cash Flow | -$2.87M | -$4.97M | -$30.14M | -$29.23M | -$61.47M | -$57.01M | -$40.85M | -$49.46M | -$54.67M | -$58.33M |
| Capital Expenditure | -$98K | $0 | -$197K | -$216K | -$3.32M | -$9.78M | -$284K | -$459K | -$737K | -$551K |
| Free Cash Flow | -$2.97M | -$4.97M | -$30.34M | -$29.45M | -$64.79M | -$66.79M | -$41.14M | -$49.92M | -$55.41M | -$58.88M |
| Investing Cash Flow | -$98K | $0 | $1.35M | -$193K | -$3.32M | -$9.78M | -$284K | -$459K | -$737K | -$551K |
| Common Stock Issued | -- | $0 | $92K | $14.72M | $0 | -- | -- | -- | $47.27M | -- |
| Share Repurchases | -- | -- | $0 | -$45K | $0 | -- | -$653K | -$1.62M | $0 | -$2.0K |
| Financing Cash Flow | $3.26M | $0 | -$18.14M | $6.37M | $25.78M | $102.1M | $59.15M | $40.31M | $45.30M | -$788K |
| Net Change in Cash | $294K | -$4.97M | -$46.93M | -$23.06M | -$39.02M | $35.33M | $18.01M | -$9.61M | -$10.11M | -$59.66M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$772K | -$952K | -$1.01M | -$893K | -$1.16M | -$1.05M | -$1.07M | -$742K |
| Depreciation & Amortization | $8.0K | $9.0K | $8.0K | $7.0K | $0 | $0 | $0 | -$1.0K |
| Stock-Based Compensation | $175K | $246K | $141K | $243K | $301K | $184K | $68K | $81K |
| Change in Receivables | $0 | $0 | $3.0K | -$3.0K | $2.0K | $0 | $3.0K | -$5.0K |
| Change in Payables | $65K | $330K | -$212K | -$230K | $34K | -$22K | $315K | $59K |
| Operating Cash Flow | -$425K | -$300K | -$1.03M | -$552K | -$844K | -$701K | -$772K | -$592K |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -- | -$592K |
| Investing Cash Flow | -- | -- | -- | -- | -- | -- | -- | $0 |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| Financing Cash Flow | -- | -- | -- | -- | -- | -- | -- | $0 |
| Net Change in Cash | $491K | -$230K | -$1.03M | -$553K | -$941K | $2.56M | -$772K | -$592K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -84500.0% | -48120.0% | -685340.0% | -1201.4% | -19484.7% | -- | -- | -36921.9% | -336.4% | -2409.4% |
| Net Profit Margin | -83520.0% | -46790.0% | -93580.0% | -1291.2% | -19786.7% | -- | -- | -36381.5% | -341.7% | -2409.2% |
| Return on Equity (ROE) | -194.0% | -226.8% | -74.2% | -97.9% | -135.6% | -64.5% | -124.0% | -62.1% | -- | -- |
| Return on Assets (ROA) | -140.8% | -169.8% | -56.6% | -58.1% | -83.0% | -54.6% | -108.0% | -55.9% | -51.4% | -155.4% |
| Current Ratio | 2.45x | 3.98x | 4.22x | 2.23x | 4.91x | 7.11x | 8.42x | 8.89x | 4.35x | 6.63x |
| Quick Ratio | 1.71x | 1.58x | 3.10x | 1.62x | 4.81x | 6.52x | 6.63x | 6.71x | 3.40x | 5.13x |
| Debt to Equity | -- | 0.00x | 0.00x | 0.58x | 0.60x | 0.08x | 0.05x | -- | -- | -- |
| Revenue Growth (YoY) | -50.0% | +100.0% | -99.8% | +634.2% | -- | -- | -- | -99.1% | +131.7% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -172.9% | -- | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -100.0% | -88.4% | -96.5% | -- | -- | -- | +1039.8% | +420.7% |
| 10Y Revenue / Share Growth | -- | -- | -- | +32.1% | -81.6% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -121033.3% | -135266.7% | -138166.7% | -84500.0% | -67883.3% | -67266.7% | -41630.0% | -53477.8% |
| Net Profit Margin | -120766.7% | -133666.7% | -136966.7% | -83520.0% | -67083.3% | -66550.0% | -40710.0% | -52000.0% |
| Return on Equity (ROE) | -373.1% | -615.0% | -319.0% | -194.0% | -143.6% | -109.1% | -384.8% | -226.9% |
| Return on Assets (ROA) | -188.9% | -264.5% | -218.2% | -140.8% | -108.1% | -84.3% | -192.0% | -169.9% |
| Current Ratio | 1.14x | 0.77x | 1.63x | 2.45x | 2.92x | 3.48x | 1.00x | 3.98x |
| Quick Ratio | 0.65x | 0.14x | 0.59x | 1.71x | 2.10x | 2.68x | 0.30x | 1.58x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | -- | 0.00x |
| Revenue Growth (YoY) | -- | -- | -100.0% | -25.0% | -- | -100.0% | +100.0% | +300.0% |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -103.3% |